210 related articles for article (PubMed ID: 16682430)
1. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.
Kim J; Reber HA; Dry SM; Elashoff D; Chen SL; Umetani N; Kitago M; Hines OJ; Kazanjian KK; Hiramatsu S; Bilchik AJ; Yong S; Shoup M; Hoon DS
Gut; 2006 Nov; 55(11):1598-605. PubMed ID: 16682430
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
3. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
4. Resectable pancreatic head adenocarcinoma: Is R0 resection an illusion? Genetic evaluation of venous resection margin affirmed unrecognized disease.
Turrini O; Gilabert M; Ewald J; Moutardier V; Delpero JR; Iovanna JL
J Visc Surg; 2017 Oct; 154(5):329-333. PubMed ID: 28844705
[TBL] [Abstract][Full Text] [Related]
5. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
[TBL] [Abstract][Full Text] [Related]
6. K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.
Ohigashi H; Ishikawa O; Sasaki Y; Yamada T; Furukawa H; Imaoka S; Kasugai T; Ishiguro S; Ueda K; Miyoshi Y; Nakamura Y
Arch Surg; 2000 Dec; 135(12):1450-5. PubMed ID: 11115351
[TBL] [Abstract][Full Text] [Related]
7. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract][Full Text] [Related]
9. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
[TBL] [Abstract][Full Text] [Related]
10. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
[TBL] [Abstract][Full Text] [Related]
15. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
16. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
17. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer.
Chen H; Tu H; Meng ZQ; Chen Z; Wang P; Liu LM
Eur J Surg Oncol; 2010 Jul; 36(7):657-62. PubMed ID: 20542658
[TBL] [Abstract][Full Text] [Related]
19. [K-ras mutations detection in paraaortic lymph nodes and its prognostic value after the surgical treatment of pancreas cancer].
Agaev BA; Muslimov GF; Iagublu VSh; Babaeva NR
Khirurgiia (Mosk); 2008; (9):64-9. PubMed ID: 18833187
[TBL] [Abstract][Full Text] [Related]
20. BRAF and K-ras gene mutations in human pancreatic cancers.
Ishimura N; Yamasawa K; Karim Rumi MA; Kadowaki Y; Ishihara S; Amano Y; Nio Y; Higami T; Kinoshita Y
Cancer Lett; 2003 Sep; 199(2):169-73. PubMed ID: 12969789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
